Presentation Cardiovascular Interventions 2025 Are Bioresorbable Scaffolds Making a Comeback? Presenter: Ajay Kirtane November 13, 2025
News Conference News AHA 2025 Lower Mortality With Complete Revascularization in Acute MI Patients With MVD Michael O'Riordan November 12, 2025
News Conference News AHA 2025 Beta-blockers Not Helpful After MI in Patients With Preserved EF Yael L. Maxwell November 12, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Conference News AHA 2025 CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia Todd Neale November 08, 2025
News Conference News TCT 2025 At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I Yael L. Maxwell November 07, 2025
News Conference News TCT 2025 SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI Caitlin E. Cox November 06, 2025
News Conference News TCT 2025 ‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains Yael L. Maxwell November 05, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Conference News TCT 2025 DOAC May Be Safer Than DAPT After Left Atrial Appendage Closure: ANDES Yael L. Maxwell November 04, 2025
News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
Presentation TCT 2025 TCT 892: A prospective, open-labelled, multicentre, observational registry of ISAR SUMMIT in CAD patients undergoing PCI in real world Indian population. Presenter: Sameer I. Dani October 28, 2025
Presentation TCT 2025 TCT 889: A Multicenter Observational Study in France Assessing Sirolimus-Eluting Biodegradable Polymer Stent for CAD Patients Undergoing PCI in Routine Clinical Practice Presenter: Adnan Kastrati October 28, 2025
Presentation TCT 2025 TCT 524: DCB-based versus DES-only Strategy for De Novo CAD across CHIP risk categories Presenter: Dong Oh Kang October 28, 2025
Presentation TCT 2025 TCT 1652: Conundrums in the Management of CAD Presenter: Sanjeev Kumar Agarwal October 28, 2025
Presentation TCT 2025 Moving to Randomized SCAI A Shock CAD Phenotype Approval Studies: Barriers & Solutions Presenter: Mitchell W. Krucoff October 28, 2025
Presentation TCT 2025 MAGICAL ISR and SV: The US IDE Trials Landscape Presenter: Azeem Latib October 27, 2025
Presentation TCT 2025 Global case presentation of Sirolimus Coated Balloon III Presenter: Ankit Gupta October 27, 2025